1802-1803 / 2437
Start
nivolumab
11/2014
6/2015
3/2015
9/2014
10/2015
2/2016
8/2015
9/2016
unitl now
Pseudoprogression vs. (true) progression
61 yo man, recurrent glioblastoma
Challenges associated with the
use of immune checkpoint inhibitors